SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    W. Liu, J. Ramirez, E. R. Gamazon, S. Mirkov, P. Chen, K. Wu, C. Sun, N. J. Cox, E. Cook, S. Das, M. J. Ratain, Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver, Human Molecular Genetics, 2014,

    CrossRef

  2. 2
    Argha Nandy, Sudeshna Gangopadhyay, Ashis Mukhopadhyay, Individualizing breast cancer treatment—The dawn of personalized medicine, Experimental Cell Research, 2014, 320, 1, 1

    CrossRef

  3. 3
    Fausto R. Loberiza, Andrew C. Cannon, Anthony J. Cannon, Philip J. Bierman, Insights on practice variations in the management of lymphoma and leukemia, Leukemia & Lymphoma, 2014, 1

    CrossRef

  4. 4
    Jie Luo, Xing-Rong Guo, Xiang-Jun Tang, Xu-Yong Sun, Zhuo-Shun Yang, Yong Zhang, Long-Jun Dai, Garth L. Warnock, Intravital biobank and personalized cancer therapy: The correlation with omics, International Journal of Cancer, 2014, 135, 7
  5. 5
    Li Liu, Jing Wu, Rong Zhong, Chen Wu, Li Zou, Beifang Yang, Wei Chen, Beibei Zhu, Shengyu Duan, Dianke Yu, Wen Tan, Shaofa Nie, Dongxin Lin, Xiaoping Miao, Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer, Molecular Carcinogenesis, 2013, 52, 12
  6. 6
    Madhu Kalia, Personalized oncology: Recent advances and future challenges, Metabolism, 2013, 62, S11

    CrossRef

  7. 7
    Liming Weng, Li Zhang, Yan Peng, R Stephanie Huang, Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy, Pharmacogenomics, 2013, 14, 3, 315

    CrossRef

  8. 8
    Xiuqin Ni, Wei Zhang, R. Stephanie Huang, Pharmacogenomics discovery and implementation in genome-wide association studies era, Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 2013, 5, 1
  9. 9
    Nagahiro Saijo, The Role of Pharmacoethnicity in the Development of Cytotoxic and Molecular Targeted Drugs in Oncology, Yonsei Medical Journal, 2013, 54, 1, 1

    CrossRef

  10. 10
    R Huang, Eric R Gamazon, Translating pharmacogenomics discoveries into the clinic: an implementation framework, Genome Medicine, 2013, 5, 10, 94

    CrossRef

  11. 11
    Michael J. Duffy, Tumor Markers in Clinical Practice: A Review Focusing on Common Solid Cancers, Medical Principles and Practice, 2013, 22, 1, 4

    CrossRef

  12. 12
    Eugenia Yiannakopoulou, OMICS, 2013,

    CrossRef

  13. 13
    Anna Scalvini, Vittorio Ferrari, Serena Bodei, Giuseppina Arcangeli, Francesca Consoli, PierFranco Spano, Sandra Sigala, Involvement of Target Gene Polymorphisms in 5-Fluorouracil Toxicity: A Case Report, Pharmacology, 2012, 89, 1-2, 99

    CrossRef

  14. 14
    Zendee Elaba, Amanda Phelps, Michael J. Murphy, Molecular diagnostic strategies: a role in the practice of dermatology, International Journal of Dermatology, 2012, 51, 11
  15. 15
    Yan Zhang, Jia Yuan, Hong Yan Zhang, Dilixia Simayi, Pin Dong Li, Ying Hong Wang, Feng Li, Wen Jie Zhang, Natural resistance to apoptosis correlates with resistance to chemotherapy in colorectal cancer cells, Clinical and Experimental Medicine, 2012, 12, 2, 97

    CrossRef

  16. 16
    Shannon N. Westin, Russell R. Broaddus, Personalized therapy in endometrial cancer: Challenges and opportunities, Cancer Biology & Therapy, 2012, 13, 1, 1

    CrossRef

  17. 17
    Salvatore Chirumbolo, Plant phytochemicals as new potential drugs for immune disorders and cancer therapy: really a promising path?, Journal of the Science of Food and Agriculture, 2012, 92, 8
  18. 18
    Susan Todd, M. Fazil Baksh, John Whitehead, Sequential methods for pharmacogenetic studies, Computational Statistics & Data Analysis, 2012, 56, 5, 1221

    CrossRef

  19. 19
    A J Atherly, D R Camidge, The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers, British Journal of Cancer, 2012, 106, 6, 1100

    CrossRef

  20. 20
    Delphine Borchiellini, Marie-Christine Etienne-Grimaldi, Juliette Thariat, Gérard Milano, The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes, Cancer Treatment Reviews, 2012, 38, 6, 737

    CrossRef

  21. 21
    Gwendolyn A. McMillin, Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 2012,

    CrossRef

  22. 22
    Li Liu, Peng Yuan, Chen Wu, Xiaomin Zhang, Feng Wang, Huan Guo, Rong Zhong, Yihua Xu, Jing Wu, Dianke Yu, Tangchun Wu, Xuemei Zhang, Shaofa Nie, Xiaoping Miao, Dongxin Lin, Assessment of XPD Lys751Gln and XRCC1 T–77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy, Lung Cancer, 2011, 73, 1, 110

    CrossRef

  23. 23
    Eric R Gamazon, R Stephanie Huang, M Eileen Dolan, Nancy J Cox, Copy number polymorphisms and anticancer pharmacogenomics, Genome Biology, 2011, 12, 5, R46

    CrossRef

  24. 24
    George C Zografos, Dimitrios H Roukos, Innovative biomarker development for personalized medicine in breast cancer care, Biomarkers in Medicine, 2011, 5, 1, 73

    CrossRef

  25. 25
    Raffaele Di Francia, Massimiliano Berretta, Oriana Catapano, Lorella M.T. Canzoniero, Luigi Formisano, Molecular diagnostics for pharmacogenomic testing of fluoropyrimidine based-therapy: costs, methods and applications, Clinical Chemistry and Laboratory Medicine, 2011, 49, 7

    CrossRef

  26. 26
    Jing Li, Martin H. Bluth, Andrea Ferreira-Gonzalez, Henry's Clinical Diagnosis and Management by Laboratory Methods, 2011,

    CrossRef

  27. 27
    Soonmo Peter Kang, Jacqueline Ramirez, Larry House, Wei Zhang, Snezana Mirkov, Wanqing Liu, Eden Haverfield, Mark J. Ratain, A pharmacogenetic study of vorinostat glucuronidation, Pharmacogenetics and Genomics, 2010, 20, 10, 638

    CrossRef

  28. 28
    Ken-ichi Fujita, Yuichi Ando, Wataru Yamamoto, Toshimichi Miya, Hisashi Endo, Yu Sunakawa, Kazuhiro Araki, Keiji Kodama, Fumio Nagashima, Wataru Ichikawa, Masaru Narabayashi, Yuko Akiyama, Kaori Kawara, Mari Shiomi, Hiroyasu Ogata, Hiroyasu Iwasa, Yasushi Okazaki, Takashi Hirose, Yasutsuna Sasaki, Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer, Cancer Chemotherapy and Pharmacology, 2010, 65, 2, 251

    CrossRef

  29. 29
    Luis Alberto Henríquez-Hernández, Adolfo Murias-Rosales, Ana González-Hernández, Antonio Cabrera de León, Nicolás Díaz-Chico, Leandro Fernández-Pérez, Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy, Cancer Epidemiology, 2010, 34, 5, 634

    CrossRef

  30. 30
    Timothy A. Yap, Shahneen K. Sandhu, Paul Workman, Johann S. de Bono, Envisioning the future of early anticancer drug development, Nature Reviews Cancer, 2010, 10, 7, 514

    CrossRef

  31. 31
    Chen Wu, Binghe Xu, Peng Yuan, Jurg Ott, Yin Guan, Yu Liu, Zhe Liu, Yuanyuan Shen, Dianke Yu, Dongxin Lin, Genome-wide examination of genetic variants associated with response to platinum-based chemotherapy in patients with small-cell lung cancer, Pharmacogenetics and Genomics, 2010, 20, 6, 389

    CrossRef

  32. 32
    Giannis Mountzios, Meletios-Athanassios Dimopoulos, Jean-Charles Soria, Despina Sanoudou, Christos A. Papadimitriou, Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: A review of published data, Critical Reviews in Oncology/Hematology, 2010, 75, 2, 94

    CrossRef

  33. 33
    Emilia Balboa, Goretti Duran, Maria Jesus Lamas, Antonio Gomez-Caamaño, Catuxa Celeiro-Muñoz, Rafael Lopez, Angel Carracedo, Francisco Barros, Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response, Pharmacogenomics, 2010, 11, 6, 747

    CrossRef

  34. 34
    C. Ahowesso, E. Piccolo, X.M. Li, S. Dulong, V. Hossard, R. La Sorda, E. Filipski, N. Tinari, F. Delaunay, S. Iacobelli, F. Lévi, Relations between strain and gender dependencies of irinotecan toxicity and UGT1A1, CES2 and TOP1 expressions in mice, Toxicology Letters, 2010, 192, 3, 395

    CrossRef

  35. 35
    M. R. Spitz, M. L. Bondy, The evolving discipline of molecular epidemiology of cancer, Carcinogenesis, 2010, 31, 1, 127

    CrossRef

  36. 36
    Arthur T. Skarin, Atlas of Diagnostic Oncology, 2010,

    CrossRef

  37. 37
    Iris Grossman, David B. Goldstein, Essentials of Genomic and Personalized Medicine, 2010,

    CrossRef

  38. 38
    Clinical Toxicology, 2010,

    CrossRef

  39. 39
    Eric R. Gamazon, Wei Zhang, R. Stephanie Huang, M. Eileen Dolan, Nancy J. Cox, A pharmacogene database enhanced by the 1000 Genomes Project, Pharmacogenetics and Genomics, 2009, 19, 10, 829

    CrossRef

  40. 40
    Richard M Logan, Advances in understanding of toxicities of treatment for head and neck cancer, Oral Oncology, 2009, 45, 10, 844

    CrossRef

  41. 41
    Leo Kager, Pharmacogenomics to improve childhood acute lymphoblastic leukaemia therapy, memo - Magazine of European Medical Oncology, 2009, 2, 2, 65

    CrossRef

  42. 42
    David M. Vail, Supporting the Veterinary Cancer Patient on Chemotherapy: Neutropenia and Gastrointestinal Toxicity, Topics in Companion Animal Medicine, 2009, 24, 3, 122

    CrossRef

  43. 43
    Hiroshi Hirata, Yuji Hinoda, Koichi Nakajima, Nobuyuki Kikuno, Yutaka Suehiro, Z. Laura Tabatabai, Nobuhisa Ishii, Rajvir Dahiya, The bcl2 −938CC Genotype Has Poor Prognosis and Lower Survival in Renal Cancer, The Journal of Urology, 2009, 182, 2, 721

    CrossRef

  44. 44
    Tracy Tucker, Marco Marra, Jan M. Friedman, Massively Parallel Sequencing,